DEUTSCHE GESELLSCHAFT FÜR PÄDIATRISCHE KARDIOLOGIE UND ANGEBORENE HERZFEHLER e.V.

Beschlossen vom Vorstand der Deutschen Gesellschaft für Pädiatrische Kardiologie und Angeborene Herzfehler e.V. am 27.04.2022

Publikationsverlauf

Artikel online veröffentlicht:
11. Februar 2025

• Literatur

• 1 Rommel JJ, Yadav PK, Stouffer GA. Causes and hemodynamic findings in chronic severe pulmonary regurgitation. Catheter Cardiovasc Interv 2018; 92 (03) E197-E203
• 2 Shimazaki Y, Blackstone EH, Kirklin JW. The natural history of isolated congenital pulmonary valve incompetence: surgical implications. Thorac Cardiovasc Surg 1984; 32 (04) 257-259
• 3 Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005; 26 (05) 433-439
• 4 Nørgaard MA, Alphonso N, Newcomb AE, Brizard CP, Cochrane AD. Absent pulmonary valve syndrome. Surgical and clinical outcome with long-term follow-up. Eur J Cardiothorac Surg 2006; 29 (05) 682-687
• 5 Chaturvedi RR, Redington AN. Pulmonary regurgitation in congenital heart disease. Heart 2007; 93 (07) 880-889
• 6 Egbe A, Conolly HM. Pulmonic regurgitation. Yeon SB, Zoghbi WA, ed. UpToDate Inc. www.uptodate.com/contents/pulmonic-regurgitation (abgerufen Juli 2021
• 7 Garty Y, Veldtman G, Lee K, Benson L. Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children. J Invasive Cardiol 2005; 17 (06) 318-322
• 8 Harrild DM, Powell AJ, Tran TX. et al. Long-term pulmonary regurgitation following balloon valvuloplasty for pulmonary stenosis risk factors and relationship to exercise capacity and ventricular volume and function. J Am Coll Cardiol 2010; 55 (10) 1041-1047
• 9 Poon LKH, Menahem S. Pulmonary regurgitation after percutaneous balloon valvoplasty for isolated pulmonary valvar stenosis in childhood. Cardiol Young 2003; 13 (05) 444-450
• 10 Bruce CJ, Connolly HM. Right-sided valve disease deserves a little more respect. Circulation 2009; 119 (20) 2726-2734
• 11 Hahn RT, Thomas JD, Khalique OK, Cavalcante JL, Praz F, Zoghbi WA. Imaging Assessment of Tricuspid Regurgitation Severity. JACC Cardiovasc Imaging 2019; 12 (03) 469-490
• 12 Zoghbi WA, Adams D, Bonow RO. et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017; 30 (04) 303-371
• 13 Lancellotti P, Tribouilloy C, Hagendorff A. et al; European Association of Echocardiography. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010; 11 (03) 223-244
• 14 Pieper PG, Silversides CK. Assessment of severity of pulmonary regurgitation. Eur J Echocardiogr 2011; 12 (02) 88 , author reply 88–89
• 15 Lancellotti P, Tribouilloy C, Hagendorff A. et al; Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013; 14 (07) 611-644
• 16 Puchalski MD, Askovich B, Sower CT, Williams RV, Minich LL, Tani LY. Pulmonary regurgitation: determining severity by echocardiography and magnetic resonance imaging. Congenit Heart Dis 2008; 3 (03) 168-175
• 17 Silversides CK, Veldtman GR, Crossin J. et al. Pressure half-time predicts hemodynamically significant pulmonary regurgitation in adult patients with repaired tetralogy of fallot. J Am Soc Echocardiogr 2003; 16 (10) 1057-1062
• 18 Van Berendoncks A, Van Grootel R, McGhie J. et al. Echocardiographic parameters of severe pulmonary regurgitation after surgical repair of tetralogy of Fallot. Congenit Heart Dis 2019; 14 (04) 628-637
• 19 Dellas C, Kammerer L, Gravenhorst V, Lotz J, Paul T, Steinmetz M. Quantification of pulmonary regurgitation and prediction of pulmonary valve replacement by echocardiography in patients with congenital heart defects in comparison to cardiac magnetic resonance imaging. Int J Cardiovasc Imaging 2018; 34 (04) 607-613
• 20 Stout KK, Daniels CJ, Aboulhosn JA. et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease. Circulation 2019; 139 (14) e698-e800
• 21 Sachdeva R, Valente AM, Armstrong AK. et al. 2020 appropriate use criteria for multimodality imaging during the follow-up care of patients with congenital heart disease: A Report of ACC/AHA/ASE/HRS/ISACHD/ SCAI/ SCCT/SCMR/SOPE. J Am Coll Cardiol 2020; 75: 657-703
• 22 Eicken A. Percutaneous Pulmonary Valve Implantation. Yeon SB, Conolly HM. , ed. UpToDate Inc./contents/percutaneous-pulmonic-valve-implantaion (abgerufen Oktober 2020
• 23 Schiller NB, Ristow B, Ren X. Echocardiographic evaluation of the pulmonic valve and pulmonary artery. Yeon SB, Manning WJ, Gaasch WH. , ed. UpToDate Inc. www.uptodate.com/contents/echocardiographic-evaluation-of-the-pulmonic-valve-and-pulmonary-artery (abgerufen Juli 2021
• 24 Ferraz Cavalcanti PE, Sá MPBO, Lins RFA. et al. Three-step preoperative sequential planning for pulmonary valve replacement in repaired tetralogy of Fallot using computed tomography. Eur J Cardiothorac Surg 2020; 59 (02) 333-340
• 25 Diller G-P, Dimopoulos K, Okonko D. et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 2005; 112 (06) 828-835
• 26 Mercer-Rosa L, Ingall E, Zhang X. et al. The impact of pulmonary insufficiency on the right ventricle: a comparison of isolated valvar pulmonary stenosis and tetralogy of fallot. Pediatr Cardiol 2015; 36 (04) 796-801
• 27 Dallaire F, Wald RM, Marelli A. The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot. Pediatr Cardiol 2017; 38 (06) 1097-1105
• 28 Baumgartner H, De Backer J, Babu-Narayan SV. et al. ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Eur Heart J 2020; 2020: ehaa554
• 29 Larios G, Yim D, Dragulescu A, Mertens L, Grosse-Wortmann L, Friedberg MK. Right ventricular function in patients with pulmonary regurgitation with versus without tetralogy of Fallot. Am Heart J 2019; 213: 8-17
• 30 Tretter JT, Friedberg MK, Wald RM, McElhinney DB. Defining and refining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: Contributions from anatomical and functional imaging. Int J Cardiol 2016; 221: 916-925
• 31 Kim YY, Ruckdeschel E. Approach to residual pulmonary valve dysfunction in adults with repaired tetralogy of Fallot. Heart 2016; 102 (19) 1520-1526
• 32 Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation 2013; 128 (17) 1855-1857
• 33 Balzer D. Pulmonary Valve Replacement for Tetralogy of Fallot. Methodist DeBakey Cardiovasc J 2019; 15 (02) 122-132
• 34 Morgan GJ. Pulmonary Regurgitation- Is the Future Percutaneous or Surgical?. Front Pediatr 2018; 6: 184
• 35 Nordmeyer J, Ewert P, Gewillig M. et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J 2019; 40 (27) 2255-2264
• 36 Georgiev S, Ewert P, Tanase D. et al. A low residual pressure gradient yields excellent long-term outcome after percutaneous pulmonary valve implantation. JACC Cardiovasc Interv 2019; 12 (16) 1594-1603
• 37 Georgiev S, Ewert P, Eicken A. et al. Munich Comparative Study: Prospective Long-Term Outcome of the Transcatheter Melody Valve Versus Surgical Pulmonary Bioprosthesis With Up to 12 Years of Follow-Up. Circ Cardiovasc Interv 2020; 13 (07) e008963
• 38 McElhinney DB, Zhang Y, Aboulhosn JA. et al. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol 2021; 78 (06) 575-589
• 39 Armstrong AK, Berger F, Jones TKJ. et al. Association between patient age at implant and outcomes after transcatheter pulmonary valve replacement in the multicenter Melody valve trials. Catheter Cardiovasc Interv 2019; 94 (04) 607-617
• 40 McElhinney DB, Sondergaard L, Armstrong AK. et al. Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol 2018; 72 (22) 2717-2728
• 41 Abdelghani M, Nassif M, Blom NA. et al. Infective Endocarditis After Melody Valve Implantation in the Pulmonary Position: A Systematic Review. J Am Heart Assoc 2018; 7 (13) e008163
• 42 Hascoet S, Mauri L, Claude C. et al. Infective Endocarditis Risk After Percutaneous Pulmonary Valve Implantation With the Melody and Sapien Valves. JACC Cardiovasc Interv 2017; 10 (05) 510-517
• 43 Lehner A, Dashkalova T, Ulrich S. et al. Intermediate outcomes of transcatheter pulmonary valve replacement with the Edwards Sapien 3 valve - German experience. Expert Rev Med Devices 2019; 16 (09) 829-834
• 44 Shahanavaz S, Zahn EM, Levi DS. et al. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. J Am Coll Cardiol 2020; 76 (24) 2847-2858
• 45 Tweddell JS, Simpson P, Li S-H. et al. Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2012; 15 (01) 27-33
• 46 Fuller S. Tetralogy of fallot and pulmonary valve replacement: timing and techniques in the asymptomatic patient. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2014; 17 (01) 30-37
• 47 Emani SM. Options for prosthetic pulmonary valve replacement. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2012; 15 (01) 34-37
• 48 Boethig D, Goerler H, Westhoff-Bleck M. et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years. Eur J Cardiothorac Surg 2007; 32 (01) 133-142
• 49 Jashari R, Goffin Y, Vanderkelen A. et al. European homograft bank: twenty years of cardiovascular tissue banking and collaboration with transplant coordination in Europe. Transplant Proc 2010; 42 (01) 183-189
• 50 Forbess JM. Conduit selection for right ventricular outflow tract reconstruction: contemporary options and outcomes. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004; 7: 115-124
• 51 Bando K, Danielson GK, Schaff HV, Mair DD, Julsrud PR, Puga FJ. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 1995; 109 (03) 509-517 , discussion 517–518
• 52 Kim WH, Min SK, Choi CH. et al. Follow-up of Shelhigh porcine pulmonic valve conduits. Ann Thorac Surg 2007; 84 (06) 2047-2050
• 53 Schiralli MP, Cholette JM, Swartz MF, Vermilion R, Meagher C, Alfieris GM. Carpentier edwards porcine valved conduit for right ventricular outflow tract reconstruction. J Card Surg 2011; 26 (06) 643-649
• 54 Boethig D, Thies WR, Hecker H, Breymann T. Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and Contegras. Eur J Cardiothorac Surg 2005; 27 (01) 58-66
• 55 Morales DLS, Braud BE, Gunter KS. et al. Encouraging results for the Contegra conduit in the problematic right ventricle-to-pulmonary artery connection. J Thorac Cardiovasc Surg 2006; 132 (03) 665-671
• 56 Breymann T, Blanz U, Wojtalik MA. et al. European Contegra multicentre study: 7-year results after 165 valved bovine jugular vein graft implantations. Thorac Cardiovasc Surg 2009; 57 (05) 257-269
• 57 Poynter JA, Eghtesady P, McCrindle BW. et al; Congenital Heart Surgeons' Society. Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg 2013; 96 (05) 1695-1701 , discussion 1701–1702
• 58 Sarikouch S, Horke A, Tudorache I. et al. Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J Cardiothorac Surg 2016; 50 (02) 281-290
• 59 Boethig D, Horke A, Hazekamp M. et al. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry data. Eur J Cardiothorac Surg 2019; 56 (03) 503-509
• 60 Haas F, Schreiber C, Hörer J, Kostolny M, Holper K, Lange R. Is there a role for mechanical valved conduits in the pulmonary position?. Ann Thorac Surg 2005; 79 (05) 1662-1667 , discussion 1667–1668
• 61 Stulak JM, Mora BN, Said SM, Schaff HV, Dearani JA. Mechanical Pulmonary Valve Replacement. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2016; 19 (01) 82-89
• 62 Dehaki MG, Al-Dairy A, Rezaei Y. et al. Mid-term outcomes of mechanical pulmonary valve replacement: a single-institutional experience of 396 patients. Gen Thorac Cardiovasc Surg 2019; 67 (03) 289-296
• 63 Pragt H, van Melle JP, Javadikasgari H. et al. Mechanical valves in the pulmonary position: An international retrospective analysis. J Thorac Cardiovasc Surg 2017; 154 (04) 1371-1378.e1
• 64 Ferraz Cavalcanti PE, Sá MP, Santos CA. et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol 2013; 62 (23) 2227-2243
• 65 National Institute for Cardiovascular Outcomes (NICOR). . Report 2017-20. www.nicor.org.uk//national-cardiac-audit-programme//congenital-heart-disease-in-children-and-adults-congenital-audit (abgerufen Okt. 2021
• 66 Dearani JA, Danielson GK, Puga FJ. et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 2003; 75 (02) 399-410 , discussion 410–411
• 67 Jang W, Kim YJ, Choi K, Lim HG, Kim WH, Lee JR. Mid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair. Eur J Cardiothorac Surg 2012; 42 (01) e1-e8
• 68 Agarwal KC, Edwards WD, Feldt RH, Danielson GK, Puga FJ, McGoon DC. Clinicopathological correlates of obstructed right-sided porcine-valved extracardiac conduits. J Thorac Cardiovasc Surg 1981; 81 (04) 591-601
• 69 Rüffer A, Purbojo A, Cicha I. et al. Early failure of xenogenous de-cellularised pulmonary valve conduits–a word of caution!. Eur J Cardiothorac Surg 2010; 38 (01) 78-85
• 70 Willetts RG, Stickley J, Drury NE. et al. Four right ventricle to pulmonary artery conduit types. J Thorac Cardiovasc Surg 2021; 162 (05) 1324-1333.e3 13241333.e3doi.org/10.1016/j.jtcvs.2020.12.144
• 71 Cocomello L, Meloni M, Rapetto F. et al. Long-Term Comparison Between Pulmonary Homograft Versus Bioprosthesis for Pulmonary Valve Replacement in Tetralogy of Fallot. J Am Heart Assoc 2019; 8 (24) e013654
• 72 Romeo JLR, Mokhles MM, van de Woestijne P. et al. Long-term clinical outcome and echocardiographic function of homografts in the right ventricular outflow tract. Eur J Cardiothorac Surg 2019; 55 (03) 518-526
• 73 Habib G, Lancellotti P, Antunes MJ. et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36 (44) 3075-3128
• 74 Giamberti A, Chessa M, Abella R. et al. Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg 2009; 88 (04) 1284-1289
• 75 Sharma A, Cote AT, Hosking MCK, Harris KC. A Systematic Review of Infective Endocarditis in Patients With Bovine Jugular Vein Valves Compared With Other Valve Types. JACC Cardiovasc Interv 2017; 10 (14) 1449-1458
• 76 Robichaud B, Hill G, Cohen S. et al. Bioprosthetic pulmonary valve endocarditis: Incidence, risk factors, and clinical outcomes. Congenit Heart Dis 2018; 13 (05) 734-739
• 77 Lee C, Park CS, Lee CH. et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 2011; 142 (02) 351-358
• 78 Boethig D, Avsar M, Bauer UM. et al. Pulmonary valve prostheses: patient's lifetime procedure load and durability. Evaluation of the German National Register for Congenital Heart Defects. Interact Cardiovasc Thorac Surg 2021;
• 79 Rüffer A, Wittmann J, Potapov S. et al. Mid-term experience with the Hancock porcine-valved Dacron conduit for right ventricular outflow tract reconstruction. Eur J Cardiothorac Surg 2012; 42 (06) 988-995
• 80 Urso S, Rega F, Meuris B. et al. The Contegra conduit in the right ventricular outflow tract is an independent risk factor for graft replacement. Eur J Cardiothorac Surg 2011; 40 (03) 603-609
• 81 Jacobs JP, Mavroudis C, Quintessenza JA. et al. Reoperations for pediatric and congenital heart disease: an analysis of the Society of Thoracic Surgeons (STS) congenital heart surgery database. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2014; 17 (01) 2-8
• 82 Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J. et al; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39 (34) 3165-3241
• 83 Canobbio MM, Warnes CA, Aboulhosn J. et al; American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research. Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2017; 135 (08) e50-e87
• 84 Liesenborghs L, Meyers S, Vanassche T, Verhamme P. Coagulation: At the heart of infective endocarditis. J Thromb Haemost 2020; 18 (05) 995-1008
• 85 Leeten K, Jacques N, Lancellotti P, Oury C. Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where do we stand?. Front Cell Dev Biol 2021; 9: 716302